Patient-reported Outcomes And Health-care Resource Utilization In Patients With Psoriasis Treated With Etanercept: Continuous Versus Interrupted Treatment
Title
Patient-reported Outcomes And Health-care Resource Utilization In Patients With Psoriasis Treated With Etanercept: Continuous Versus Interrupted Treatment
Creator
Gelfand J M; Kimball A B; Mostow E N; Chiou C F; Patel V; Xia H A; Freundlich B; Stevens S R
Publisher
Value in Health
Date
2008
2008-05
Subject
arthritis; atopic-dermatitis; Business & Economics; clinical trial; depression; double-blind; efficacy; etanercept; Health Care Sciences & Services; health-care resource utilization; monotherapy; phase-iii trial; plaque psoriasis; psoriasis; quality-of-life; quality-of-life; therapy; tumor necrosis factor
Identifier
Format
Journal Article or Conference Abstract Publication
URL Address
Search for Full-text
Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
400-407
Issue
3
Volume
11
Citation
Gelfand J M; Kimball A B; Mostow E N; Chiou C F; Patel V; Xia H A; Freundlich B; Stevens S R, “Patient-reported Outcomes And Health-care Resource Utilization In Patients With Psoriasis Treated With Etanercept: Continuous Versus Interrupted Treatment,” NEOMED Bibliography Database, accessed April 27, 2024, https://neomed.omeka.net/items/show/9681.